drugset / Trial / NCT00230516
Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects
RandomizedCrossoverOpen-label
Summary
This study is intended to evaluate whether intravenous (iv) esomeprazole (Nexium® ) offers better intragastric acid suppression than iv lansoprazole (Prevacid ®
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 40 mg | Intravenous |
| Subject | Lansoprazole | Other / unclassified | 30 mg | Intravenous |
Indications
No indication recorded.